MCM
ISEE

Manchester Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Manchester Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,829
Closed -$172K – 930
2014
Q4 		$172K Hold
3,829
– – 0.02% 406
2014
Q3 		$149K Hold
3,829
– – 0.02% 443
2014
Q2 		$162K Hold
3,829
– – 0.02% 428
2014
Q1 		$137K Buy
+3,829
New +$129K 0.02% 449

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manchester Capital Management's ISEE Position: Q1 2015 in Review

Manchester Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2015, closing a stake of 3,829 shares — an estimated $172K sold.

Manchester Capital Management first reported a position in ISEE in Q1 2014 and held it in 4 quarters. The position peaked at $172K in Q4 2014. 129 funds tracked by Wall St. Rank hold ISEE as of Q1 2015.

  • Manchester Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Manchester Capital Management sold 3,829 IVERIC bio, Inc. Common Stock shares in Q1 2015, an estimated $172K.
  • Manchester Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Manchester Capital Management's IVERIC bio, Inc. Common Stock position peaked at $172K in Q4 2014.
  • 129 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.